Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
FMBIO Stock Summary
In the News
FMBIO Financial details
Company Rating
-
Market Cap
0
Income
199.56M
Revenue
751.11M
Book val./share
24.29
Cash/share
46.63
Dividend
-
Dividend %
-
Employees
2K
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
0.57
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
0.56
LT Debt / Equity
0.56
-
-
EPS (TTM)
1.77
EPS next Y
-
EPS next Q
-
EPS this Y
82.29%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
12.53%
Revenue last 5Y
3.69%
Revenue Q/Q
-3.74%
EPS Q/Q
-12.24%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
1%
ROE
7%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
27%
Payout
36%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
26.06-26.6099
52W High
+1.73%
52W Low
+1.73%
RSI
-
Rel Volume
0.69
Avg Volume
6.35K
Volume
4.37K
Perf Week
0%
Perf Month
0%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
1.09995
-
-
Volatility
0%, 0%
Prev Close
0%
Price
26.45
Change
1.5%
FMBIO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.18 | 6.43 | 6.92 | 6.39 | 6.6 | |
Net income per share | 0.97 | 1.53 | 1.84 | 0.96 | 1.75 | |
Operating cash flow per share | 2.31 | 2.46 | 2.09 | 1.2 | 0 | |
Free cash flow per share | 2.15 | 2.19 | 1.9 | 1.1 | 0 | |
Cash per share | 21.99 | 24.9 | 29.22 | 37.39 | 46.28 | |
Book value per share | 18.39 | 19.98 | 21.83 | 23.87 | 24.11 | |
Tangible book value per share | 10.95 | 12.29 | 13.77 | 15.59 | 24.11 | |
Share holders equity per share | 18.39 | 19.98 | 21.83 | 23.87 | 24.11 | |
Interest debt per share | 8.11 | 10.25 | 16.02 | 15.18 | 13.76 | |
Market cap | 2.44B | 2.04B | 2.5B | 1.79B | 2.33B | |
Enterprise value | 2.87B | 2.74B | 3.83B | 2.32B | 1.74B | |
P/E ratio | 24.75 | 12.91 | 12.54 | 16.63 | 11.68 | |
Price to sales ratio | 3.89 | 3.08 | 3.33 | 2.49 | 3.1 | |
POCF ratio | 10.38 | 8.05 | 11.03 | 13.29 | 0 | |
PFCF ratio | 11.15 | 9.04 | 12.11 | 14.5 | 0 | |
P/B Ratio | 1.31 | 0.99 | 1.06 | 0.67 | 0.85 | |
PTB ratio | 1.31 | 0.99 | 1.06 | 0.67 | 0.85 | |
EV to sales | 4.58 | 4.14 | 5.1 | 3.22 | 2.31 | |
Enterprise value over EBITDA | 11.61 | 9.56 | 9.51 | 9.89 | 5.62 | |
EV to operating cash flow | 12.25 | 10.81 | 16.88 | 17.15 | 0 | |
EV to free cash flow | 13.16 | 12.14 | 18.54 | 18.72 | 0 | |
Earnings yield | 0.04 | 0.08 | 0.08 | 0.06 | 0.09 | |
Free cash flow yield | 0.09 | 0.11 | 0.08 | 0.07 | 0 | |
Debt to equity | 0.42 | 0.48 | 0.69 | 0.61 | 0.56 | |
Debt to assets | 0.06 | 0.06 | 0.09 | 0.08 | 0.07 | |
Net debt to EBITDA | 1.77 | 2.44 | 3.3 | 2.23 | -1.91 | |
Current ratio | 45.35 | 47.82 | 41.41 | 46.74 | 55.05 | |
Interest coverage | 5.98 | 3.99 | 3.41 | 2.88 | 8.05 | |
Income quality | 2.38 | 1.6 | 1.14 | 1.25 | 0 | |
Dividend Yield | 0.02 | 0.02 | 0.02 | 0.04 | 0 | |
Payout ratio | 0.38 | 0.28 | 0.28 | 0.67 | 0 | |
Sales general and administrative to revenue | 0.41 | 0.42 | 0.36 | 0.43 | 0.4 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.05 | 0.05 | 0.05 | 0.04 | 0 | |
Capex to operating cash flow | -0.07 | -0.11 | -0.09 | -0.08 | 0 | |
Capex to revenue | -0.03 | -0.04 | -0.03 | -0.02 | 0 | |
Capex to depreciation | -0.74 | -1.19 | -0.76 | -0.41 | 0 | |
Stock based compensation to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0 | |
Graham number | 20.03 | 26.27 | 30.06 | 22.67 | 30.84 | |
ROIC | 0.04 | 0.07 | 0.07 | 0.04 | 0.05 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham Net | -96.78 | -104.08 | -110.32 | -120.1 | -117.94 | |
Working capital | 11.03B | 12.02B | 13.56B | 16.24B | 17.15B | |
Tangible asset value | 1.11B | 1.26B | 1.5B | 1.76B | 2.74B | |
Net current asset value | -929.41M | -1.18B | -1.58B | -1.56B | -1.57B | |
Invested capital | 0.42 | 0.48 | 0.69 | 0.61 | 0.56 | |
Average receivables | 249.86M | 233.59M | 341.66M | 485.17M | 499.88M | |
Average payables | 256.03M | 252.73M | 296.14M | 345.32M | 336.1M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 128.96 | 135.65 | 212.57 | 269.96 | 226.94 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 2.83 | 2.69 | 1.72 | 1.35 | 1.61 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.05 | 0.08 | 0.08 | 0.04 | 0.07 | |
Capex per share | -0.16 | -0.27 | -0.19 | -0.1 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2021-12-31 for Q4
Metric | History | 2020-12-31 | 2021-03-31 | 2021-06-30 | 2021-09-30 | 2021-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.55 | 1.65 | 1.69 | 1.69 | 1.62 | |
Net income per share | 0.37 | 0.4 | 0.45 | 0.49 | 0.43 | |
Operating cash flow per share | 0.35 | 1.59 | -0.54 | 0.93 | 0 | |
Free cash flow per share | 0.32 | 1.57 | -0.56 | 0.91 | 0 | |
Cash per share | 37.23 | 37.19 | 41.66 | 45.51 | 46.63 | |
Book value per share | 23.77 | 23.46 | 23.96 | 24.12 | 24.29 | |
Tangible book value per share | 15.53 | 23.46 | 23.96 | 24.12 | 24.29 | |
Share holders equity per share | 23.77 | 23.46 | 23.96 | 24.12 | 24.29 | |
Interest debt per share | 14.59 | 12.37 | 12.36 | 12.36 | 13.61 | |
Market cap | 1.8B | 2.48B | 2.24B | 2.15B | 2.31B | |
Enterprise value | 2.32B | 2.86B | 2.08B | 1.61B | 1.72B | |
P/E ratio | 10.83 | 13.76 | 10.95 | 9.78 | 11.91 | |
Price to sales ratio | 10.25 | 13.26 | 11.75 | 11.27 | 12.62 | |
POCF ratio | 44.85 | 13.81 | -36.47 | 20.54 | 0 | |
PFCF ratio | 49.27 | 13.96 | -35.61 | 20.94 | 0 | |
P/B Ratio | 0.67 | 0.93 | 0.83 | 0.79 | 0.84 | |
PTB ratio | 0.67 | 0.93 | 0.83 | 0.79 | 0.84 | |
EV to sales | 13.22 | 15.28 | 10.91 | 8.44 | 9.39 | |
Enterprise value over EBITDA | 35.25 | 36.13 | 24.35 | 17.82 | 23.1 | |
EV to operating cash flow | 57.85 | 15.92 | -33.87 | 15.38 | 0 | |
EV to free cash flow | 63.54 | 16.09 | -33.07 | 15.68 | 0 | |
Earnings yield | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | |
Free cash flow yield | 0.02 | 0.07 | -0.03 | 0.05 | 0 | |
Debt to equity | 0.61 | 0.52 | 0.51 | 0.51 | 0.56 | |
Debt to assets | 0.08 | 0.07 | 0.06 | 0.06 | 0.07 | |
Net debt to EBITDA | 7.92 | 4.79 | -1.87 | -5.98 | -7.94 | |
Current ratio | 46.74 | 40.78 | 48.88 | 50.18 | 55.05 | |
Interest coverage | 5 | 7.22 | 8.12 | 8.84 | 8.08 | |
Income quality | 0.97 | 3.99 | -1.2 | 1.9 | 0 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Payout ratio | 0.48 | 0.45 | 0.39 | 0.36 | 0 | |
Sales general and administrative to revenue | 0.5 | 0.41 | 0.39 | 0.38 | 0.43 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.04 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.09 | -0.01 | 0.02 | -0.02 | 0 | |
Capex to revenue | -0.02 | -0.01 | -0.01 | -0.01 | 0 | |
Capex to depreciation | -0.54 | -0.28 | -0.23 | -0.31 | 0 | |
Stock based compensation to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0 | |
Graham number | 14.02 | 14.5 | 15.63 | 16.24 | 15.33 | |
ROIC | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | -119.6 | -123.74 | -122.57 | -120.12 | -118.83 | |
Working capital | 16.24B | 16.43B | 16.94B | 17.05B | 17.15B | |
Tangible asset value | 1.76B | 2.65B | 2.7B | 2.72B | 2.74B | |
Net current asset value | -1.56B | -1.71B | -1.63B | -1.66B | -1.57B | |
Invested capital | 0.61 | 0.52 | 0.51 | 0.51 | 0.56 | |
Average receivables | 572.87M | 503.13M | 493.71M | 493.84M | 470.39M | |
Average payables | 407.84M | 384.07M | 383.45M | 350.2M | 331.89M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 272.7 | 227.99 | 242.72 | 223.97 | 229.36 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.33 | 0.39 | 0.37 | 0.4 | 0.39 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex per share | -0.03 | -0.02 | -0.01 | -0.02 | 0 |
FMBIO Frequently Asked Questions
What is First Midwest Bancorp, Inc. stock symbol ?
First Midwest Bancorp, Inc. is a US stock , located in Chicago of Il and trading under the symbol FMBIO
What is First Midwest Bancorp, Inc. stock quote today ?
First Midwest Bancorp, Inc. stock price is $26.45 today.
Is First Midwest Bancorp, Inc. stock public?
Yes, First Midwest Bancorp, Inc. is a publicly traded company.